The recent rapid increase in the prevalence of emerging tobacco-and nicotine-containing products, such as ecigarettes, is being driven in part by their reduced-risk potential compared to tobacco smoking. In this study, we examined emission levels for selected cigarette smoke constituents, so-called "Hoffmann analytes", and in vitro toxicity of aerosol from a novel tobacco vapor product (NTV). The NTV thermally vaporizes a nicotine-free carrier liquid to form an aerosol which then passes through tobacco, where it absorbs tobacco-derived flavors and nicotine. The NTV results were compared with those for 3R4F cigarette smoke. Chemical analysis of the NTV aerosol demonstrated that Hoffmann analyte levels were substantially lower than in 3R4F smoke and that the most were below quantifiable levels. Results from in vitro bacterial reverse mutation, micronucleus and neutral red uptake assays showed that, in contrast with 3R4F smoke, the NTV aerosol failed to demonstrate any measurable genotoxicity or cytotoxicity. The temperature of tobacco during NTV use was measured at approximately 30°C, which may explain the lower Hoffmann analyte emission and in vitro toxicity levels. These results suggest that the aerosol from the NTV has a very different toxicological profile when compared with combustible cigarette smoke.
Introduction
Smoking is a known risk factor for smoking-related diseases, such as lung cancer, chronic obstructive pulmonary disease and cardiovascular disease (Forey et al., 2011; Go et al., 2014; Vineis et al., 2004) . Cigarette smoke is a complex mixture containing over eight thousands chemicals, many of which have been reported as bioactive substances generated during the processes of tobacco combustion (Rodgman and Perfetti, 2013) . The levels of such bioactive substances has been reported to be lower in tobacco products which do not combust tobacco during use, such as smokeless tobacco and heated tobacco products (Hatsukami et al., 2007; Stabbert et al., 2003) . This has led to the suggestion that the use of such products could potentially help in reducing the harm associated with continued tobacco use (tobacco harm reduction concept).
To date, there is a wide variety of traditional and non-traditional smokeless tobacco products, such as moist snuff, snus, chewing and dissolvable tobacco available in several countries around the world. More recently, there has been a rise in the use of novel tobacco-and nicotine-containing products, such as e-cigarettes (Adkison et al., 2013) and heated tobacco products. The latter are generally separated into two categories based on the heating mechanisms utilized; namely carbon heat source at the tip of the product or a battery-powered electrical heating device (Borgerding et al., 1998; Sakaguchi et al., 2014; Smith et al., 2016) . The health risks associated with the use of traditional non-combusted products have been extensively investigated, in particular for the Swedish smokeless tobacco product snus where there is rich epidemiological data on the health consequences associated with use of the product (Foulds et al., 2003) . However, the health risks of more recent product innovations, such as e-cigarettes and electrically-heated tobacco products, are less well understood and are the subject of active scientific and public debate.
Japan Tobacco Inc. has recently developed a novel tobacco vapor product (NTV) as an alternative to traditional tobacco products. The product is composed of a puff activated electrical heating device with battery, a cartridge containing nicotine-free carrier liquid and an atomizer (cartomizer) and a tobacco capsule containing granulated tobacco. The NTV generates a thermally-vaporized aerosol which then passes through the tobacco capsule before being inhaled. In doing so, evaporated tobacco-derived flavors and nicotine are infused into the vapor. This mechanism of tobacco vapor generation differs from most existing heated tobacco products in that it does not heat the tobacco directly during use. Instead, the tobacco is indirectly warmed by the vapor passing through it. The NTV also differs from most e-cigarettes as the carrier liquid does not contain nicotine.
The purpose of this study was to understand the chemical characteristics and in vitro mutagenicity, genotoxicity and cytotoxicity of the NTV aerosol. We evaluated the emission levels of over 40 chemicals known to be biologically active tobacco smoke constituents (Hoffmann and Hoffmann, 1998; Hoffmann and Wynder, 1986) . These analytes have been specified as priority constituents required, or proposed, for regulatory reporting (Health Canada, 2000; U.S. Food and Drug Administration, 2012; World Health Organization, 2008) . In addition to the chemical analysis of the emissions, in vitro toxicological activities of the aerosol as a whole, rather than individual chemical constituents, were also investigated using the bacterial reverse mutation test (Ames assay), the in vitro micronucleus (MN) assay and the neutral red uptake (NRU) assay. These three in vitro toxicological assays form part of the regulatory reporting requirements for tobacco products in Canada (Health Canada, 2000) and are widely used for the safety screening of chemicals and pharmaceuticals. The Kentucky reference cigarette 3R4F, as a representative of combustible cigarettes (Roemer et al., 2004) , was used as a positive control in both emission chemistry and in vitro toxicological experiments. Finally, in order to correlate the findings with the heating conditions of tobacco, the temperature inside the tobacco capsule of the NTV was also measures during use.
Materials and methods

Test items
The Kentucky reference 3R4F cigarettes were purchased from the University of Kentucky, Kentucky Tobacco Research and Development Center (Lexington, KY, USA). The NTV were obtained from Japan Tobacco Inc. (Tokyo, Japan). The NTV consists of three modules: a puffactivated electrically heating devise with rechargeable-battery, a cartomizer containing a nicotine-free carrier liquid (i.e., propylene glycol, glycerol and triacetin) and a tobacco capsule containing granulated tobacco (Fig. 1) . All test items, except for the heating device, were stored at 4°C ± 3°C until use.
Smoke and aerosol generation
All the test items were conditioned for at least 48 h under 22°C ± 1°C at 60% relative humidity according to the International Organization for Standardization (ISO) 3402 (ISO, 1999) . The battery of the heating device was fully charged prior to aerosol generation. The mainstream 3R4F cigarette smoke and aerosol from NTV were generated by machine smoking using the Health Canada Intense (HCI) puffing conditions (i.e., 55 mL puff volume, 2 s duration, 30 s puff interval and bell-shape puff profile (Health Canada, 2000) ). The 3R4F cigarette was smoked until butt length of 35 mm in accordance with ISO 4387 (ISO, 2000) . For the NTV, the total puff number for each aerosol collection per tobacco capsule was set as 70 based on the product specification.
Chemical analysis
The chemical analysis was conducted by Labstat International ULC (Kitchener, ON, Canada) in compliance with principles of Good Laboratory Practice. The yields of major smoke constituents (i.e., TPM, water, nicotine and carbon monoxide (CO)) and the 43 Hoffmann analytes were determined using analytical methods specified in the Supplementary Table 1 . Propylene glycol, glycerol and triacetin, which are components of the carrier liquid, were also analyzed using the method specified in the Supplementary Table 1 . Room air blank samples for each analyte were also analyzed to identify any contaminants in the ambient air, analytical reagents or equipment. Mean value and 95% confidence interval (95CI) were reported for each analyte from five independent measurements. In case that at least one measurement value was below limit of quantification (LOQ) and median value was higher than LOQ, the median was given but the 95CI was not calculated. When the median was below LOQ or limit of detection (LOD), the LOQ or LOD value was provided as a reference value.
Temperature measurement inside tobacco capsule
The temperature inside the tobacco capsule of the NTV during aerosol generation was measured. A type K thermocouple (φ 0.15 mm) (CHINO; Tokyo, Japan) was inserted into the center of the tobacco capsule. The aerosol from the NTV was generated as described above in section 2.2. The temperature was recorded over 70 puffs (2100 s) during machine smoking using data logger ZR-RX25 (Omron; Kyoto, Japan). The mean values from three independent measurements were calculated for each measured time point.
In vitro toxicological testing
The Ames assay and in vitro MN assay were performed to evaluate the mutagenicity and genotoxicity of the NTV aerosol and 3R4F cigarette smoke. The NRU assay was applied for cytotoxicity evaluation. All in vitro studies, including test sample preparation processes, were conducted in Labstat International ULC (Kitchener, ON, Canada) in compliance with the principles of Good Laboratory Practice.
Sample preparation
The NTV aerosol and 3R4F mainstream smoke were generated using a rotary smoking machine as described in section 2.2. The total particulate matter (TPM) was collected on a 92-mm Cambridge filter pad. The pad was extracted with dimethyl sulfoxide (DMSO) purchased from Sigma Aldrich (St. Louis, MO, USA) and prepared to 10 mg TPM/mL solution for the 3R4F and 50 mg TPM/mL solution for the NTV. The gas-vapor phase (GVP) was collected simultaneously with the TPM collection. The smoke or NTV aerosol fraction which passes through the filter pad was bubbled into 15 mL of ice-cold calcium-and magnesiumfree phosphate buffer saline (CMF-PBS). Subsequently, fresh CMF-PBS was added to achieve a final concentration of 10 mg TPM equivalent/ mL for the 3R4F and 50 mg TPM equivalent/mL for the NTV. The TPM samples for Ames and MN assays were stored below −70°C in a cryofreezer until testing. The TPM and GVP samples for NRU assay were prepared within an hour prior to testing.
Ames assay
The Ames assay was performed in general accordance with Health Y. Takahashi et al. Regulatory Toxicology and Pharmacology 92 (2018) After the incubation, the reaction mixture was mixed with molten top agar and over layered on a minimal glucose agar plate. The plate was incubated at 37°C ± 1°C for 48-72 h, and then the number of revertants per plate was counted automatically. The mean number of revertants was calculated from triplicate plates. Two independent experiments were conducted with the test sample prepared independently.
The test samples were evaluated as mutagenic if the results in any strains ± S9 combinations are shown to give reproducible dose-dependent increase in revertants and at least two-fold increase in the number of revertants over concurrent solvent control at one or more dose concentrations (Cariello and Piegorsch, 1996) . To compare the mutagenic activity between test samples, the slope parameter (i.e., a first-order coefficient) was calculated from linear regression analysis over the linear portion of the dose-response curve using JMP version 10.0.2 (SAS Institute Japan; Tokyo, Japan).
In vitro micronucleus assay
The MN assay was performed in general accordance with Health Canada Official Method T-503, In vitro Micronucleus Assay for Mainstream Tobacco Smoke (Health Canada, 2004b) . The CHO-WBL cell line purchased from Sigma Aldrich (St. Lois, MO, USA) was used for the assay. The cells were maintained in Ham's nutrient mixture F12 medium (Sigma Aldrich; St. Louis, MO, USA) supplemented with 10% fetal bovine serum (Sigma Aldrich; St. Louis, MO, USA) in a 5% CO 2 incubator at 37°C ± 2°C. The TPM fraction was assayed in three treatment schedules: short term exposure without or with metabolic activation and long term exposure without metabolic activation.
Cell suspension (1 × 10 5 cells/mL) was pre-incubated for 24 h ± 3 h before treatment. For the short term exposure, the cell culture was treated with serially diluted test samples for 3 h ± 15 min without or with S9-mix containing Aroclor 1254-induced rat liver homogenate (Molecular Toxicology, Inc.; Boone, NC, USA). After removal of the test sample, the cells were incubated for 27 h ± 1 h. For the long term exposure, the cells were incubated with test sample for 30 h ± 1 h in the absence of the metabolic activation system. Colchicine (Sigma Aldrich; St. Louis, MO, USA) and mitomycin C (Sigma Aldrich; St. Louis, MO, USA) in the absence metabolic activation, and cyclophosphamide (Sigma Aldrich; St. Louis, MO, USA) in the presence of metabolic activation were applied as positive controls. DMSO alone was used as solvent control in all experiments. After the incubation period, the cells were detached and the number of viable cells was counted with hemocytometer using trypan blue to calculate the relative increase in cell count as a cytotoxicity parameter. The remaining cells were fixed with a solution of glacial acetic acid/methanol (1:3, v/v), placed on glass slides by cytospin centrifugation and stained with acridine orange. All slides were blindly coded and examined manually using a fluorescence microscopy. The number of micronucleated cells per 2000 cells (1000 cells/slide, duplicate culture) was scored and the MN cell frequency (%MN) was calculated. The experiments were conducted twice independently. Genotoxicity for each test sample was evaluated as previously described (Matsushima et al., 1999) . The Cochran-Armitage binomial trend test was used to examine dose dependency of MN frequency. The Fisher's exact test was used to evaluate significant increase of MN frequency over concurrent solvent control at one or more dose concentrations. If both the statistical test results were significant and reproducible in two independent experiments, the test sample was evaluated as genotoxic. For the comparison of genotoxic activity between test samples, logistic regression analysis was performed with data up to a concentration at which the MN frequency was the highest. The slope parameter of the logistic function was defined as the genotoxic activity. The data analysis was conducted using JMP version 10.0.2 (SAS Institute Japan; Tokyo, Japan).
Neutral red uptake assay
The NRU assay was performed using CHO-WBL cell line in general accordance with Health Canada Official Method T-502, Neutral Red Uptake Assay for Mainstream Tobacco Smoke (Health Canada, 2004c) . The cells were maintained as described in section 2.5.3.
The CHO-WBL cell suspension (5 × 10 4 cells/mL) was pre-cultured for 24 h in 96-well microtiter plates. The cells were treated with the TPM or GVP fraction for 24 h. Sodium lauryl sulfate was used as the positive control. DMSO or CMF-PBS alone was used as solvent control for TPM or GVP testing, respectively. Quadruplicate 96-well plates were assayed per test sample in a single experiment. The treated cells were washed with CMF-PBS, and then incubated with medium containing 50 μg/mL neutral red dye for 3 h. The cells were then fixed with 1% formalin solution for 1-2 min. After removal of the fixative, the neutral red dye taken up by the viable cells was extracted by adding 50% ethanol containing 1% (v/v) acetic acid, and the absorbance at 540 nm was measured using a microplate reader. The experiments were conducted twice independently. Cytotoxicity for each treatment level was expressed as a relative absorbance to concurrent solvent control. To enable the estimation of the IC 50 value for comparison of cytotoxic activity between test samples, non-linear regression analysis for the relationship between relative absorbance and concentration was performed based on least squares method using a logistic function. The IC 50 value was calculated by inverse estimation of the effective concentration at which the absorbance was reduced by 50% of the concurrent solvent control value. The calculations were conducted using JMP version 10.0.2 (SAS Institute Japan, Tokyo, Japan).
Results
Smoke and aerosol characterization
The TPM, nicotine, water and CO yields from the NTV and the 3R4F cigarette are presented in Table 1 . The yields of the liquid components of the tested NTV, i.e., propylene glycol, glycerol and triacetin are also provided. The TPM yield of the NTV was approximately twice as high as the TPM of the 3R4F cigarette when compared on a per tobacco capsule/cigarette basis (91.7 mg for NTV (70 puffs) vs. 44.5 mg for 3R4F (10.9 puffs)). The TPM content from the NTV was predominantly composed of water and the liquid components, which accounted for more than 90% (w/w) of the total TPM amount. In contrast, the 3R4F cigarette smoke TPM contained around 37% (w/w) of water and less than 10% of glycerol and triacetin which are commonly used cigarette ingredients (Davis and Nielsen, 1999) . The nicotine yield from the NTV was approximately 50% lower than that of the 3R4F. The amount of other constituents trapped as TPM was more than 60% lower in the NTV aerosol compared to the 3R4F cigarette smoke (8.75 mg for NTV vs. 24.6 mg for 3R4F). Regarding the gaseous phase, the CO yield from the NTV was below LOD whereas that from the 3R4F was 31.2 mg per cigarette.
Hoffmann analytes
The analyses results of the Hoffmann analytes, as well as the air blank values for each analyte, are shown in Table 2 . The LOD and LOQ values for each analyte are also provided. The LOD and LOQ levels were different between the test items due to the differences of the number of test items and/or extraction solution volume per analysis. For the 3R4F cigarette smoke, chromium, nickel and selenium were below LOD and the other analytes were quantifiable. In contrast, all the analytes, except for formaldehyde, acetone and ammonia, were below LOQ or LOD for the NTV. Formaldehyde and acetone were also detected in air blank samples with quantifiable levels, whereas ammonia was below LOQ. The yields of those two carbonyls in the NTV aerosol were slightly higher than the air blank values; however the yields were 94% (formaldehyde) and 98% (acetone) lower than those for the 3R4F cigarette. The ammonia yield in the NTV aerosol was 58% lower than that from the 3R4F cigarette smoke.
Temperature inside tobacco capsule
The temperature inside the NTV tobacco capsule was measured throughout aerosol generation under HCI puffing regime (Fig. 2) . The initial temperature before first puff was 22°C which was comparable to the ambient air temperature specified in ISO 3402 (ISO, 1999) . The temperature gradually increased with increasing puff counts and reached approximately 30°C at the 70th puff, which is the final puff count for single tobacco capsule use.
In vitro toxicological testing
Ames assay
The TPM fractions of the NTV aerosol and the 3R4F cigarette smoke were tested in the Ames assay to assess mutagenicity. The assay was performed using five tester strains, TA98, TA100, TA1535, TA1537 and TA102, in both presence and absence of exogenous metabolic activation system. The dose-response curves in the assay conditions, which displayed clearly positive responses for either the NTV or the 3R4F cigarette, are shown in Fig. 3 . The results of the other conditions are given in the Supplementary Fig. 1 . In the presence of metabolic activation, the 3R4F TPM gave reproducible positive responses in TA98, TA100 and TA1537 up to 500 μg TPM per plate (Fig. 3A, C and D) . In the absence of metabolic activation, the 3R4F TPM was positive in TA98 and TA1537 (Fig. 3B and E) . In contrast, the TPM fraction of the NTV aerosol did not induce significant increase in the number of revertants up to 5000 μg TPM/plate under any of the assay conditions. The slope parameters of the dose-response curves in each assay condition are summarized in Table 3 for comparison of mutagenic activity between test items. The values from both two replicate assays were positive and significant from zero in TA98, TA100 and TA1537 with S9, and TA98 and TA1537 without S9 for the 3R4F cigarette, while not significant in any assay conditions for the NTV.
In vitro micronucleus assay
To assess the genotoxicity of the TPM fractions for the NTV aerosol and the 3R4F cigarette smoke, the MN assay was performed under three conditions, 3 h treatment without and with metabolic activation and 24 h treatment without metabolic activation. The dose-response curves given from each condition are shown in Fig. 4 . The 3R4F TPM displayed clear increases in MN frequency under all three conditions. For the TPM fraction of the NTV aerosol, there were no statistically significant increases of MN frequency up to 1000 μg TPM/mL under any of the assay conditions with 3 h treatment. Moreover, the result of 24 h continuous treatment also did not exhibit positive response, even at 5-fold higher TPM concentrations compared to the 3R4F. The slope parameters of each dose-response curve are shown in Table 4 for comparison of genotoxic activity between the test samples. The values from two replicate assays were significantly different from zero for the 3R4F cigarette, while not significant in any conditions for the NTV.
Neutral red uptake assay
Both the TPM and GVP fractions prepared from the 3R4F cigarette and the NTV were applied to the NRU assay to assess cytotoxicity. The dose-response curves for each fraction were shown in Fig. 5 . Neither the TPM fraction nor the GVP fraction derived from the NTV showed cytotoxic responses up to 1000 μg TPM/mL or μg TPM equivalent/mL, so that IC 50 values could not be calculated. In contrast, both 3R4F TPM and GVP displayed clear cytotoxic responses. The mean IC 50 values of the 3R4F were 96.7 μg TPM/mL for TPM and 136.0 μg TPM equivalent/ mL for GVP.
Discussion
The objective of the current study was to characterize the aerosol from the NTV in terms of emission yields of the Hoffmann analytes, in vitro genotoxicity and cytotoxicity. The study conditions were designed in general accordance with Health Canada official methods incorporated by the Tobacco Reporting Regulations in Canada (Health Canada, 2000) . The results were then compared with results from the 3R4F cigarette smoke (as a positive control). The yields per tobacco capsule for NTV and per cigarette for 3R4F are presented. Values are mean ± 95CI from five independent measurements. Abbreviations; 95CI: 95% confidence interval, LOD: limit of detection and LOQ: limit of quantification.
Aerosol characterization
Major smoke constituent analyses, i.e., TPM, water, nicotine and CO, and additional analyses for propylene glycol and glycerol were performed to characterize aerosol composition of the tested NTV (Table 1 ). The major constituents of the tested NTV aerosol were water, propylene glycol, glycerol and triacetin which are the liquid components vaporized to form the aerosol. Propylene glycol, glycerol and triacetin are widely used in food, pharmaceuticals, cosmetics and tobacco products. Several animal studies assessed toxicity of inhaled propylene glycol and glycerol individually (Renne et al., 1992; Robertson et al., 1947; Suber et al., 1989; Werley et al., 2011) . More recently, toxicity of an aerosol generated from a mixture of propylene glycol and glycerol as base e-cigarette liquid components have also been assessed in a 90-day OECD sub-chronic inhalation study in rats (Phillips et The yields per tobacco capsule for NTV (70 puffs) and per cigarette for 3R4F (9.6-13.3 puffs) are presented. The yields of air blank samples are also given. Mean ± 95CI from five independent measurements are shown. In case that at least one measurement was below LOQ and the median was above LOQ, the median is given. If the median was below LOD or LOQ, the LOD or LOQ value is given. Abbreviations; 95CI: 95% confidence interval, LOD: limit of detection, LOQ: limit of quantification, PAH: polycyclic aromatic hydrocarbon, PQS: pyridine, quinoline and styrene HCN: hydrogen cyanide, NNN: nitrosonornicotine, NAT: nitrosoabatabine, NAB: nitrosoabanasine, NNK: 4-(methylnitrosoamino)-1-(3-pyridyl)-1-butanone, NO: nitric oxide and NOx: nitrogen oxides.
Y. Takahashi et al. Regulatory Toxicology and Pharmacology 92 (2018) 94-103 consistently suggested no clear evidence of systemic toxicity. Some of them reported minimal to mild irritation effect on upper respiratory tract at high dose exposures without any changes in lungs or other organs. The irritation effect was considered as an adaptive response to dehydration due to hygroscopic nature of polyols, rather than toxicologically relevant response (Phillips et al., 2017; Suber et al., 1989) . Moreover, the Committee for Risk Assessment of the European Chemicals Agency has disagreed to classify propylene glycol as irritant substance(European Chemicals Agency, 2016). Triacetin has also been studied in rodents and didn't show any systemic toxicity in repeated exposure via inhalation route (Fiume et al., 2003; OECD SIDS, 2000) . The amount of other constituents collected on the Cambridge filter pad was more than 60% lower for the NTV aerosol compared with the 3R4F cigarette smoke despite much higher number of puffs for the NTV (70 for NTV vs. 10.9 for 3R4F). Regarding gaseous phase, CO was not detected in aerosol from the NTV. Based on these results, the NTV aerosol is chemically less complex than combustible cigarette smoke. The nicotine yield was approximately 50% lower in the NTV (70 puffs per tobacco capsule) in comparison to the 3R4F (10.9 puffs per cigarette). The difference was substantial when compared on a per puff basis (0.016 mg for NTV and 0.19 mg for 3R4F), which suggests that the NTV is not expected to deliver higher amounts of nicotine to human subjects in comparison to a combustible cigarette.
Hoffmann analytes
In the NTV aerosol, the majority of Hoffmann analytes were reported to be below the LOQ, while formaldehyde and acetone were reduced by 94% and 99%, respectively, when comparing on per the tobacco capsule with the 3R4F cigarette, and slightly above the levels measured in the air blank samples (Table 2) . Ammonia showed a reduction rate of 58% compared to the 3R4F and of 90% when expressed on per puff basis.
Possible sources for both carbonyls have not been further investigated in this study. Ammonia has been reported to occur in both cigarette smoke and unburnt tobacco (Counts et al., 2005; Eldridge et al., 2015) . Considering the low temperature inside the tobacco capsule, the ammonia detected in the NTV aerosol may be attributed to evaporation from the tobacco itself.
The combustion or pyrolysis temperature of tobacco is known to be an important factor in the formation of biologically active smoke constituents (Hoffmann and Wynder, 1986) . For example, aromatic amines and heterocyclic amines, which are both mutagenic chemical species, are formed via pyrolysis and pyrosynthsis of nitrogenous proteins and amino acids in tobacco (Manabe and Wada, 1990; Patrianakos and Hoffmann, 1979) . A number of studies have reported that lowering the temperature of the tobacco during product use contributes to reductions of certain smoke constituents (Baker, 2006; Forster et al., 2015; Torikai et al., 2004) . Therefore, as an approach to significantly reduce combustion-derived smoke constituents, new-technology tobacco products, which are intended to heat but not burn tobacco, have been developed by tobacco companies over the past two decades. In fact, some heated tobacco products have extensively been investigated their characteristics in terms of the difference from combustible cigarettes. The aerosols of those heated tobacco products are generated from tobacco directly heated at 240-350°C with carbon heat source or electrically controlled heating device, not to cause significant pyrolysis of tobacco constituents (Breheny et al., 2017; Smith et al., 2016) . It has consistently been demonstrated that the emission of harmful constituents from those heated tobacco products is clearly lower than combustible cigarettes (Borgerding et al., 1998; Foy et al., 2004; Roemer et al., 2004; Stabbert et al., 2003; Zenzen et al., 2012) . The NTV in the present study is unique in terms of aerosol generation; the thermally-vaporized nicotine-free carrier liquid passes through the tobacco capsule and delivers tobacco-derived flavors and nicotine. The tobacco is not heated directly, so that the maximum temperature inside the tobacco capsule was approximately 30°C (Fig. 2) . Although the tobacco heating mechanisms is unique, no combustion of tobacco as with the existing heated tobacco products would theoretically result in lower formation of harmful constituents highlighted as causing concern by regulatory authorities.
In vitro toxicology
Results of the three in vitro assays demonstrated that the TPM and GVP of the NTV did not induce significant toxic responses over background (i.e., solvent control) under the conditions used in this study Tables 3 and 4 ). In the Ames assay, cigarette TPM is known to induce mutagenic responses in TA98, TA100 and TA1537 strains (Baker et al., 2004; Counts et al., 2006; Roemer et al., 2002) . The current results for the 3R4F TPM were consistent with these publications. It has been reported that tobacco pyrolysate was not detectably mutagenic when generated at temperature below 400°C (White et al., 2001 ). In addition, aromatic amines and polycyclic aromatic hydrocarbons, known as two predominant chemical classes accounting for the mutagenicity of cigarette TPM detected in the Ames assay (DeMarini, 1998), were below LOD or LOQ levels for the NTV aerosol.
The MN assay did not show a significant genotoxic response for the TPM fractions of NTV under the present test conditions (Fig. 4) . Since the MN frequencies for the NTV appeared to be slightly increased in a dose-dependent manner, although the trend was not statistically significant, a quantitative comparison of the slope parameters of the doseresponse curves between NTV and 3R4F was also performed. This comparison revealed that the slopes for NTV were at least 89% lower than those for 3R4F, confirming that the in vitro genotoxicity of the NTV aerosol was substantially lower than 3R4F cigarette smoke.
Cytotoxicity, assessed using the NRU assay, was not observed for the TPM and GVP from the NTV (Fig. 5) . Both TPM and GVP fractions from combustible cigarettes were cytotoxic in this study, in agreement with previous literature (Johnson et al., 2009) . Several carbonyl compounds and phenolic compounds have been reported to contribute to the cytotoxicity of cigarette smoke (Tewes et al., 2003) . The results of chemical analysis indicated that only formaldehyde and acetone were detected in the NTV aerosol, albeit at significantly lower levels compared to 3R4F cigarette smoke. However, the lack of measurable cytotoxicity for the NTV in this study suggests that these emission levels do not induce cytotoxic responses under the conditions tested.
Overall, the reduced in vitro toxicological activities of the aerosol from NTV observed in this study could, in part, be attributed to the lower heating temperature of the tobacco during use, resulting in the lower yields of tobacco combustion-derived smoke constituents. The results are also in line with previous publications indicating aerosols from heated (but not burned) tobacco products have a simpler chemical profile and elicit reduced responses for the mutagenicity, genotoxicity and cytotoxicity in comparison to combustible cigarette (Bombick et al., 1998; Ishikawa et al., 2016; Roemer et al., 2004; Schaller et al., 2016; Tewes et al., 2003; Zenzen et al., 2012) .
In addition to the standard in vitro toxicological assays, an increasing number of in vitro studies using disease-related endpoints (e.g. inflammation and oxidative stress) as well as systems toxicology approaches have been performed recently to investigate a wider and more detailed toxicological profile for several heated tobacco products (Breheny et al., 2017; Fields et al., 2005; Gonzalez-Suarez et al., 2016; Iskandar et al., 2017; Kogel et al., 2015 Kogel et al., , 2016 Poussin et al., 2016; van der Toorn et al., 2015) . The studies have revealed that the heating but not burning tobacco lowers impacts on various key cellular events in disease pathways. Further comprehensive in vitro studies discussed above would help to understand the detailed toxicological profile of the NTV aerosol better. 
Conclusion
Based on the chemical and in vitro toxicological evaluations under the conditions in this study, the aerosol from NTV showed distinctively lower yields of certain biologically-active smoke constituents as well as lower in vitro genotoxic and cytotoxic responses. These product characteristics seem to arise from the low tobacco heating temperature, which was measured at approximately 30°C. Further investigations on exposure levels of smoke constituents to human subjects under actual usage conditions, and on biological responses in clinical and non-clinical endpoints, could substantiate the potential of NTV to reduce the health risks associated with the continued use of tobacco products.
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